T-Lymphocyte Subsets

"T-Lymphocyte Subsets" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A classification of T-lymphocytes, especially into helper/inducer, suppressor/effector, and cytotoxic subsets, based on structurally or functionally different populations of cells.

Descriptor ID	D016176
MeSH Number(s)	A11.118.637.555.567.550.500 A11.118.637.555.567.569.500 A15.145.229.637.555.567.550.500 A15.145.229.637.555.567.569.500 A15.382.490.555.567.550.500 A15.382.490.555.567.569.500
Concept/Terms	T-Lymphocyte Subsets T-Lymphocyte Subsets Subset, T-Lymphocyte Subsets, T-Lymphocyte T Lymphocyte Subsets T-Lymphocyte Subset T-Cell Subsets Subset, T-Cell Subsets, T-Cell T Cell Subsets T-Cell Subset

Below are MeSH descriptors whose meaning is more general than "T-Lymphocyte Subsets".

Anatomy [A]
Cells [A11]
Blood Cells [A11.118]
Leukocytes [A11.118.637]
Leukocytes, Mononuclear [A11.118.637.555]
Lymphocytes [A11.118.637.555.567]
Lymphocyte Subsets [A11.118.637.555.567.550]
T-Lymphocyte Subsets [A11.118.637.555.567.550.500]
T-Lymphocytes [A11.118.637.555.567.569]
T-Lymphocyte Subsets [A11.118.637.555.567.569.500]
Hemic and Immune Systems [A15]
Blood [A15.145]
Blood Cells [A15.145.229]
Leukocytes [A15.145.229.637]
Leukocytes, Mononuclear [A15.145.229.637.555]
Lymphocytes [A15.145.229.637.555.567]
Lymphocyte Subsets [A15.145.229.637.555.567.550]
T-Lymphocyte Subsets [A15.145.229.637.555.567.550.500]
T-Lymphocytes [A15.145.229.637.555.567.569]
T-Lymphocyte Subsets [A15.145.229.637.555.567.569.500]
Immune System [A15.382]
Leukocytes [A15.382.490]
Leukocytes, Mononuclear [A15.382.490.555]
Lymphocytes [A15.382.490.555.567]
Lymphocyte Subsets [A15.382.490.555.567.550]
T-Lymphocyte Subsets [A15.382.490.555.567.550.500]
T-Lymphocytes [A15.382.490.555.567.569]
T-Lymphocyte Subsets [A15.382.490.555.567.569.500]

Below are MeSH descriptors whose meaning is related to "T-Lymphocyte Subsets".

Below are MeSH descriptors whose meaning is more specific than "T-Lymphocyte Subsets".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "T-Lymphocyte Subsets" by people in this website by year, and whether "T-Lymphocyte Subsets" was a major or minor topic of these publications.

Bar chart showing 77 publications over 26 distinct years, with a maximum of 9 publications in 2008

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1993	1	0	1
1996	2	1	3
1997	1	0	1
1998	1	0	1
1999	1	1	2
2001	1	1	2
2002	0	2	2
2003	3	1	4
2004	0	2	2
2006	2	2	4
2007	2	2	4
2008	5	4	9
2009	2	1	3
2010	1	2	3
2011	2	2	4
2012	2	1	3
2013	0	2	2
2014	1	1	2
2015	3	5	8
2016	0	2	2
2017	1	1	2
2018	1	2	3
2019	2	2	4
2020	0	3	3
2021	1	0	1
2022	0	2	2

Below are the most recent publications written about "T-Lymphocyte Subsets" by people in Profiles.

Shah A, Storek J, Woolson R, Pinckney A, Keyes-Elstein L, Wallace PK, Sempowski GD, McSweeney P, Mayes MD, Crofford L, Csuka ME, Phillips K, Khanna D, Simms R, Ballen K, LeClercq S, Clair WS, Nixon AB, Nash R, Wener M, Brasington R, Silver R, Griffith LM, Furst DE, Goldmuntz E, Sullivan KM. Lymphocyte subset abnormalities in early severe scleroderma favor a Th2 phenotype and are not altered by prior immunosuppressive therapy. Rheumatology (Oxford). 2022 10 06; 61(10):4155-4162.

View in: PubMed
Oberholtzer N, Quinn KM, Chakraborty P, Mehrotra S. New Developments in T Cell Immunometabolism and Implications for Cancer Immunotherapy. Cells. 2022 02 17; 11(4).

View in: PubMed
Chandrasekaran S, Funk CR, Kleber T, Paulos CM, Shanmugam M, Waller EK. Strategies to Overcome Failures in T-Cell Immunotherapies by Targeting PI3K-d and -?. Front Immunol. 2021; 12:718621.

View in: PubMed
Zhou ER, Arce S. Key Players and Biomarkers of the Adaptive Immune System in the Pathogenesis of Sarcoidosis. Int J Mol Sci. 2020 Oct 07; 21(19).

View in: PubMed
Haque A, Samantaray S, Knaryan VH, Capone M, Hossain A, Matzelle D, Chandran R, Shields DC, Farrand AQ, Boger HA, Banik NL. Calpain mediated expansion of CD4+ cytotoxic T cells in rodent models of Parkinson's disease. Exp Neurol. 2020 08; 330:113315.

View in: PubMed
Nguyen H, Alawieh A, Bastian D, Kuril S, Dai M, Daenthanasanmak A, Zhang M, Iamsawat S, Schutt SD, Wu Y, Sleiman MM, Shetty A, Atkinson C, Sun S, Varela JC, Tomlinson S, Yu XZ. Targeting the Complement Alternative Pathway Permits Graft Versus Leukemia Activity while Preventing Graft Versus Host Disease. Clin Cancer Res. 2020 07 01; 26(13):3481-3490.

View in: PubMed
Jackson L, Li W, Abdul Y, Dong G, Baban B, Ergul A. Diabetic Stroke Promotes a Sexually Dimorphic Expansion of T Cells. Neuromolecular Med. 2019 12; 21(4):445-453.

View in: PubMed
Gandy KAO, Zhang J, Nagarkatti P, Nagarkatti M. Resveratrol (3, 5, 4'-Trihydroxy-trans-Stilbene) Attenuates a Mouse Model of Multiple Sclerosis by Altering the miR-124/Sphingosine Kinase 1 Axis in Encephalitogenic T Cells in the Brain. J Neuroimmune Pharmacol. 2019 09; 14(3):462-477.

View in: PubMed
Alrafas HR, Busbee PB, Nagarkatti M, Nagarkatti PS. Resveratrol modulates the gut microbiota to prevent murine colitis development through induction of Tregs and suppression of Th17 cells. J Leukoc Biol. 2019 08; 106(2):467-480.

View in: PubMed
Bartee MY, Dryja PC, Bartee E. Chimeric tumor modeling reveals role of partial PDL1 expression in resistance to virally induced immunotherapy. J Immunother Cancer. 2019 01 16; 7(1):11.

View in: PubMed

People

Explore

Similar Concepts

Top Journals